Single-use systems streamline CGT manufacturing by reducing cleaning validation and enabling quick changeovers, essential for ...

As interest in injectable biologics for cancer and other diseases continues to surge, CDMO Simtra BioPharma Solutions is catching the wave stateside with plans for a new commercial manufacturing ...

Lifecore Biomedical, Inc. announced a new 10-year commercial manufacturing and supply agreement with one of its existing customers to support the development of a novel ophthalmic therapeutic. This ...

COLLEGE STATION, Texas, Sept. 15, 2025 /PRNewswire/ -- Matica Biotechnology, Inc. (Matica Bio), a leading contract development and manufacturing organization (CDMO) specializing in viral vector ...

BEND, Ore.--(BUSINESS WIRE)--Serán Bioscience (“Serán” or “the Company”), a leading contract development and manufacturing organization (CDMO) providing a comprehensive suite of development, ...

Adeno-associated virus (AAV) vectors play a pivotal role in gene therapy, delivering therapeutic genes with high precision and safety. However, a significant challenge in the biomanufacturing of these ...

Curran Simpson, President and CEO, highlighted strong late-stage clinical progress and the company's positioning for multiple gene therapy launches, stating the business is “in-store for an exciting ...

Greenwich LifeSciences updates on commercial manufacturing of GP2 and prepares for BLA filing for GLSI-100 in breast cancer treatment. Greenwich LifeSciences, Inc. announced progress in the commercial ...

WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that two of its manufacturing facilities in Wuxi –Drug Product Facility 5 ...

Partners Have Successfully Revitalized Companies in a Wide Range of Industries CHICAGO, Feb. 4, 2025 /PRNewswire/ -- Whitebridge Capital Partners, LLC, is seeking commercial and industrial ...